Julia Robinson is our clinical and science editor.
The latest information about the novel coronavirus identified in Wuhan, China, and advice on how pharmacists can help concerned patients and the public.
Pharmacies are experiencing difficulties sourcing some commonly used asthma inhalers, following a surge in demand caused by the COVID-19 pandemic, The Pharmaceutical Journal can reveal.
Patients taking angiotensin converting enzyme inhibitors or angiotensin receptor blockers have been “strongly” advised to continue taking their medication amid fears that it could predispose them to adverse outcomes should they become infected with COVID-19.
Recent blog posts
Our research briefings are concise and informative; they keep readers up to date with the latest developments in science and clinical research — from novel uses for existing drugs, to studies assessing potential new treatments.
In 2018, our most popular research briefings covered new areas of research that have been particularly topical this year — including medical cannabis, new antibiotics and e-cigarettes — as well as areas that have long been of interest to pharmacists, such as pain management and adherence.
Julia Robinson summarises the pertinent themes discussed during The Pharmaceutical Journal’s Twitter chat held on Wednesday 12 December 2018.